FAT1 and head and neck squamous cell carcinoma: This bioinformatic discovery was supported by cell viability assays showing that HNSCC cell lines with mutant FAT1 were less sensitive to CPI‐613 compared to those with wild‐type FAT1 (Figure S8, Supporting Information).